Nonexcisional, Minimally Invasive Rejuvenation of the Neck Using Radiofrequency Tissue Tightening (FaceTite™)
Article information
Abstract
Background
Noninvasive radiofrequency (RF) and lasers have been used for skin tightening and body contouring since the 1990s. The safety, efficacy, and patient satisfaction with the procedure using a novel RF device (BodyTite™; Invasix Ltd, Yokneam Ilit, Israel) were evaluated.
Methods
We retrospectively included 13 patients who were treated with the BodyTite™ to rejuvenate neck skin from May 2012 to May 2014. The power of the device was set between 10 and 15 W. The target temperature was set at 38degrees C. Three independent evaluators were asked to grade baseline and 6- to 12-month follow-up photographs using a comprehensive quantitative 4-point laxity grading scale. All patients were asked to rate their satisfaction with the aesthetic outcome and quality of life after treatment.
Results
Grading results of baseline and follow-up photographs of patients were statistically significant with an average grade improvement of 1.01 points on the 4 point scale. Using a patient satisfaction scale, patients were also significantly more satisfied (poor, 0%; fair, 15%; good, 46%; and excellent, 39%). There were transient complications, such as minimal erythema, mild edema, and focal hardness, which resolved spontaneously within 1 week. There were no significant adverse effects or complications.
Conclusions
The BodyTite™ is a minimally invasive, RF treatment that was demonstrated to improve skin laxity without significant adverse effects or complications. The BodyTite™ provides a nonsurgical option for the safe and effective rejuvenation of neck skin under local anesthesia.
INTRODUCTION
There are nonsurgical and nonexcisional alternatives for lower face and neck lifts, including traditional liposuction, laser-assisted liposuction (LAL), skin surface skin tightening technologies, and minimally invasive skin tightening (MIST). Although traditional tumescent neck liposuction is highly effective at contouring and fat removal, it fails to address the residual skin laxity left behind completely in a number of cases [1-3]. While easily facilitating lipolysis and removal, neck LAL fails to manage residual skin laxity adequately [4].
In contrast to skin surface technologies, the use of needle electrodes or fiber cannula MIST delivers the laser or radiofrequency (RF) energy immediately into the dermis or subdermal tissue, maximizing efficacy in treating lower face and neck laxity [5,6].
Noninvasive RF and lasers have been used for skin tightening and body contouring since the 1990s. An RF device (BodyTite™; Invasix Ltd, Yokneam Ilit, Israel) was introduced in 2008 to contract skin and soft tissue, and treat subcutaneous adipose regions. The RF energy elicits its effects on the fibroseptal network and triggers skin tightening and soft tissue contraction [7,8]. RF energy induces thermal stimulation to cause skin surface contraction of up to 45% [9].
The purpose of our study was to evaluate the safety, efficacy, and patient satisfaction with the neck tightening procedure using a novel RF device (BodyTite™) and using FaceTite™ as the hand piece.
METHODS
In this study, we retrospectively included 13 patients who were treated with the RF device (BodyTite™) to rejuvenate neck skin under local anesthesia from May 2012 to May 2014. All participants provided verbal and written consent before enrollment. Patient consent for photography was also taken before treatment. Pre- and post-treatment photographs were also obtained. Blinded grading was performed by three independent evaluators, including plastic surgeons and nurses, using a quantitative 4-point grading scale to assess changes in skin laxity [10] (Table 1). All patients were asked to assess their satisfaction with the aesthetic outcome and quality of life after treatment using a 4-point subjective scale of excellent, good, fair, and poor.
Inclusion criteria were good health and mild to severe laxity (minimum baseline laxity, grade 2). Exclusion criteria consisted of any injection history such as silicone, fat, collagen, or a synthetic material; bleeding or coagulation disorder; history of a hypertrophic scar or keloid; and isotretinoin treatment in the past 12 months. Other exclusion criteria included a compromised immune system, impaired wound healing, collagen vascular disease, an implantable electronic device (e.g., pacemaker), or active infection. Participants were required to be available for post-treatment follow-up evaluations.
The RF treatments were performed by the corresponding author (ESP). The FaceTite™ was used as the hand piece for treatment (Fig. 1). Before treatment, the patient’s skin was cleansed with betadine (Purdue Pharma, Stamford, Connecticut). Patients received a local injection of 1:100,000 epinephrine mixed with 0.5% lidocaine at the incision site. An additional local anesthetic (mean quantity, 100 mL tumescent solution) was used in the submental and lateral neck regions. Settings were 10 and 15 W, with an endpoint epidermal skin temperature of 38°C. Postoperatively, the patient’s skin was cleansed with normal saline, and Vaseline gauze was applied. Patients were allowed to return to normal activities immediately, were prohibited from wearing makeup for 24 hours, and were asked to avoid sun exposure for 14 days. Patients were followed up 12 months after treatment. Patients were required to report any discomfort, adverse effects, and complications during or following treatment. At follow-up visits, patients were asked to rate their overall satisfaction.
Standardized photographs were taken for the patient at baseline on the day of treatment and during the follow-up visits. The photographs were cropped and randomized equally. Three independent blinded evaluators graded the images using the Quantitative Comprehensive Grading Scale for facial and neck laxity [10] (Table 1, Fig. 2). Blinded evaluators categorized the patient’s laxity grade based on the specific findings (e.g., neck strands). Mean baseline and follow-up grades with standard deviations were calculated for each patient. Pre- and post-treatment grades were compared using the Wilcoxon signed-rank test by SPSS version 20.0 (SPSS Inc., Chicago, IL, USA). Differences were considered statistically significant when P was less than 0.05.
RESULTS
The mean baseline and follow-up laxity grades based on the 4-point laxity grading scale were 3.04 and 2.03, respectively (Table 2). Grading results of baseline and follow-up photographs of patients showed statistically significant improvement in neck skin laxity with an average grade improvement of 1.01 points on the 4-point laxity grading scale (P<0.05). Clinical outcomes of patients after RF treatment are shown in Fig. 3 to 5. The results of the grading evaluation and statistical analysis for the patient are shown in Table 2. Patient satisfaction with RF treatment was high: 39% reported excellent satisfaction; 46%, good; 15%, fair; and 0%, poor.
There were transient complications, such as minimal erythema, mild edema, and focal hardness, which resolved spontaneously within 1 week. Subjects who took pain relievers preemptively reported no pain during the postoperative period. There were no surface irregularities, numbness, or difficulty speaking, and there were no significant adverse effects or complications. Patients could return to their normal activity immediately after treatment.
DISCUSSION
In previous studies using various laser- and light-based devices, dermal temperatures greater than 55°C are required to induce collagen denaturation; this denaturation is followed by neocollagenesis during a 6- to 12-month period [11]. The disadvantage of prior modalities is that they rely on skin surface infrared temperature measurements. The advantage of the current RF device is that, using real-time temperature feedback, it allows a specific target temperature at the dermal treatment site.
Furthermore, the time-at-temperature can produce adequate thermal denaturation. Dermal thermal injury is followed by progressive neocollagenesis and correlates with progressive tissue tightening [11]. The BodyTite™ system’s mechanism protects from thermal injury. During our study, that temperature was set at 38°C to avoid injury to the skin. Other studies used cut-off settings of skin temperature between 40 and 42°C [12,13].
The FaceTite™ is composed of a silicone-coated, solid RF-emitting probe with a plastic tip to avoid subdermal “end hit” thermal injuries. The FaceTite™ has internal and external electrodes. The RF energy is delivered from the internal to the external electrode, coagulating subcutaneous fat in close proximity to the electrode in the superficial subdermal space while gradually heating the papillary dermis, as the electrodes glide along the epidermal surface. The thermal denaturation of the reticular dermis, allows the papillary dermis to be preserved. The external electrode has special sensors that deliver information to the console to which the FaceTite™ is connected, which responds by turning the RF energy on or off. Consequentially, rising dermal temperatures rapidly turn off the RF energy when the conditions approach dangerous thermal levels. The temperature is monitored 10 times per millisecond. The safe, prolonged exposure of thermal energy tightens the subdermal tissue and optimizes soft tissue contraction and tightening. It is believed that thermal injury to the dermis triggers dermal remodeling and neocollagenesis [14].
Previous studies quantitatively evaluated nonsurgical skin tightening techniques using the same quantitative 4-point grading scale as our study; however, the current device showed a much higher efficacy in treating skin laxity. In prior studies, a 0.075 to 0.236 mean laxity grade improvement per treatment using RF or infrared laser or light devices was reported [15-18]. The current device showed a mean grade improvement of 1.01, significantly higher than all prior studies.
In this study, there were no significant adverse effects or complications. Patient satisfaction was high. As a nonsurgical, minimally invasive treatment under local anesthesia, the current device offer a reasonable option for patients who are afraid of surgical procedures or surgical scars. In addition, patients increasingly want to resume their normal activities quickly after the procedure and also worry about long-lasting or significant side effects.
With regard to long-term effects, we monitored patient responses to RF treatment up to 2 years in our outpatient clinic. There was no significant worsening of skin laxity during the follow-up period. In addition, no patients considered a revision procedure. During the 6- to 12-month follow-up period, collagen denaturation and neocollagenesis were induced [11]. If necessary, a revision procedure can be considered 1 year after the initial treatment.
The limitations of this study include a lack of comparison with a control group treated by other modalities. A blinded and randomized comparative study could help identify the effects of RF treatment more precisely. Second, the number of patients is relatively small. A large population study could help evaluate the results more accurately. Lastly, the term of the study is relatively short. Longer-term follow-up visits are needed to evaluate the course of the results.
The BodyTite™ is a minimally invasive RF treatment that improved skin laxity without significant adverse effects or complications. The BodyTite™ provides a nonsurgical option for the safe and effective for treatment of neck skin laxity under local anesthesia.
Acknowledgements
This work was supported by the Soonchunhyang University Research Fund.
Notes
No potential conflict of interest relevant to this article was reported.
PATIENT CONSENT
Patients provided written consent for the use of their images.